News Quantified

KMDA – kamada ltd. - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender

Kamada (NASDAQ:KMDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026

Kamada Ltd (KMDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements [Yahoo! Finance]

Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth

2.8%

MISS

-1.3%

BEAT

1.3%

IN-LINE

7.9%

BEAT

Form 6-K KAMADA LTD For: Dec 18

Form 6-K KAMADA LTD For: Dec 10

Form 6-K KAMADA LTD For: Dec 08

Form 6-K/A KAMADA LTD For: Dec 02

Form 6-K KAMADA LTD For: Sep 30

Top News Gainers

11/21 Form 6-K KAMADA LTD For: Nov 21 13.5%

1/21 Kamada Announces $25 Million Private Placement with FIMI Opportunity Fund 6.4%

12/9 Kamada Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized Hyper-Immune Globulin Product 4.5%

11/13 Q3/2019 9/30/2019 EPS 0.140 ZacksConsensus 0.090 ActVsEst 0.050 - Beat 3.9%

2/5 Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2019 Financial Results and Host Conference Call on February 12, 2020 3.2%

11/12 Form 6-K KAMADA LTD For: Nov 12 2.7%

12/4 Form 6-K KAMADA LTD For: Dec 04 2.2%

10/25 Kamada Ltd. (NASDAQ: KMDA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 2.0%

11/7 Kamada to Report Third Quarter 2019 Financial Results and Host Conference Call on November 13 1.3%

2/19 Kamada Ltd. (NASDAQ: KMDA) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 1.3%

Top News Decliners

3/11 Kamada Provides Update on Progress Related to its Proprietary Hyper-Immunoglobulin (IgGs) Platform Technology including its Commercial Anti-Rabies IgG and its Pipeline Products Anti-Corona (COVID-19) and Anti-Zika IgGs -14.2%

2/12 Q4/2019 12/31/2019 EPS 0.130 ZacksConsensus 0.130 ActVsEst 0.000 - In-Line -8.2%

2/18 Form SC 13G/A KAMADA LTD Filed by: MEITAV DASH INVESTMENTS LTD -7.4%

1/7 Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2019 and Provides Full-Year 2020 Revenue Guidance -5.4%

1/9 Kamada Ltd. (NASDAQ: KMDA) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -4.3%

12/2 Form SC 13D/A KAMADA LTD Filed by: Brosh Capital Partners L.P. -3.9%

12/16 Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of Inhaled AAT for the Treatment of Alpha-1 Antitrypsin Deficiency -3.8%

1/24 Kamada Ltd. (NASDAQ: KMDA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -3.7%

10/29 Kamada and Kedrion Biopharma Announce Publication of Results from the Registration Study of KEDRAB® (Rabies Immune Globulin [Human]) in Human Vaccines & Immunotherapeutics Medical Journal -3.6%

12/23 Kamada Ltd. (NASDAQ: KMDA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock. -3.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day